Literature DB >> 9830465

Radiation-induced gastrointestinal toxicity. Pathophysiology, approaches to treatment and prophylaxis.

J Classen1, C Belka, F Paulsen, W Budach, W Hoffmann, M Bamberg.   

Abstract

BACKGROUND: Gastrointestinal toxicity is frequently observed during radiotherapy of malignancies in the abdomen and pelvis. The proposed pathophysiology of radiation enteritis is complex and a variety of different treatment strategies have been suggested for the management of acute radiation-induced diarrhea.
MATERIAL AND METHODS: Data are presented from an extensive review of the current literature.
RESULTS: Radiation-induced diarrhea results from a variety of different pathophysiological mechanisms including malabsorption of bile salts and lactose, imbalances in local bacterial flora and changes in the intestinal patterns of motility. Up to date acute radiation diarrhea is predominantly treated symptomatically using opioide derivates (loperamide) or adsorbants of bile salts such as smectite. Clinical trials have been performed using L. acidophilus, smectite or sucralfate for diarrhea prophylaxis with moderate reduction of acute symptoms.
CONCLUSIONS: Further evaluation of strategies for diarrhea prophylaxis is warranted. Due to the complex nature of radiation enteritis a multimodal approach taking into account alterations in intestinal motility patterns, malabsorption of bile salts and an imbalance of mucosal bacterial flora may offer new perspectives.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9830465

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  16 in total

Review 1.  Radiation enteritis.

Authors:  Ali H Harb; Carla Abou Fadel; Ala I Sharara
Journal:  Curr Gastroenterol Rep       Date:  2014

2.  Small bowel toxicity after high dose spot scanning-based proton beam therapy for paraspinal/retroperitoneal neoplasms.

Authors:  R A Schneider; V Vitolo; F Albertini; T Koch; C Ares; A Lomax; G Goitein; E B Hug
Journal:  Strahlenther Onkol       Date:  2013-09-21       Impact factor: 3.621

Review 3.  Gastrointestinal toxicity associated to radiation therapy.

Authors:  Mario López Rodríguez; Margarita Martín Martín; Laura Cerezo Padellano; Alicia Marín Palomo; Yamile Ibáñez Puebla
Journal:  Clin Transl Oncol       Date:  2010-08       Impact factor: 3.405

4.  Dynamic antagonism between RNA-binding protein CUGBP2 and cyclooxygenase-2-mediated prostaglandin E2 in radiation damage.

Authors:  Nabendu Murmu; Jesse Jung; Debnath Mukhopadhyay; Courtney W Houchen; Terrence E Riehl; William F Stenson; Aubrey R Morrison; Thiruvengadam Arumugam; Brian K Dieckgraefe; Shrikant Anant
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-09       Impact factor: 11.205

Review 5.  Gastrointestinal radiation injury: symptoms, risk factors and mechanisms.

Authors:  Abobakr K Shadad; Frank J Sullivan; Joseph D Martin; Laurence J Egan
Journal:  World J Gastroenterol       Date:  2013-01-14       Impact factor: 5.742

6.  Recent advances in the management of radiation colitis.

Authors:  Jannis Kountouras; Christos Zavos
Journal:  World J Gastroenterol       Date:  2008-12-28       Impact factor: 5.742

Review 7.  Molecular markers of radiation-related normal tissue toxicity.

Authors:  Paul Okunieff; Yuhchyau Chen; David J Maguire; Amy K Huser
Journal:  Cancer Metastasis Rev       Date:  2008-09       Impact factor: 9.264

Review 8.  Relationship and interactions of curcumin with radiation therapy.

Authors:  Vivek Verma
Journal:  World J Clin Oncol       Date:  2016-06-10

9.  An Integrated Multi-Omic Approach to Assess Radiation Injury on the Host-Microbiome Axis.

Authors:  Maryam Goudarzi; Tytus D Mak; Jonathan P Jacobs; Bo-Hyun Moon; Steven J Strawn; Jonathan Braun; David J Brenner; Albert J Fornace; Heng-Hong Li
Journal:  Radiat Res       Date:  2016-08-11       Impact factor: 2.841

Review 10.  [Normal tissue: radiosensitivity, toxicity, consequences for planning].

Authors:  A Rühle; P E Huber
Journal:  Radiologe       Date:  2018-08       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.